Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Profiling the Cell-Type Specific Effects of Psilocybin in Medial Prefrontal CortexhBiological Psychiatry · 2026-04-24The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measuresJournal of Psychopharmacology · 2025-12-31Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging studyUnknown journal · 2025-11-30Acute Kidney Failure and Myocarditis Triggered by Magic Mushroom Toxicity in a Patient With Prior Cocaine ExposureCureus · 2025-11-11Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Unknown journal · 2025-10-2213. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-08The psychedelic psilocybin and light exposure have similar and synergistic effects on gene expression patterns in the visual cortexMolecular Brain · 2025-03-17Cell-type specific transcriptional modulation by psilocybin induces sustained plasticity in mouse medial prefrontal cortexbioRxiv · 2025-01-07Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysis.Unknown journal · 2024-08-20The association between diverse psychological protocols and the efficacy of psilocybin-assisted therapy for clinical depressive symptoms: a Bayesian meta-analysis.Unknown journal · 2024-08-12Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptoriScience · 2024-04-08Psychotropics: A scientific, regulatory, and public view on the medicinal uses of cannabinoids and psilocybinMedical Writing · 2023-12-10A suite of engineered mice for interrogating psychedelic drug actionsbioRxiv · 2023-09-25Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled studyBrain Behavior and Immunity · 2023-09-06118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-09Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-04Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteersmedRxiv · 2022-10-31Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.Unknown journal · 2022-02-10Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.Unknown journal · 2021-10-07Spontaneous and deliberate creative cognition during and after psilocybin exposure.Translational Psychiatry · 2021-04-07Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybinNeuropsychopharmacology · 2020-05-22P.324 Acute effects of psilocybin on glutamate concentration levels, functional connectivity and subjective stateEuropean Neuropsychopharmacology · 2020-01-27Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The International Journal of Neuropsychopharmacology · 2016-07-04